Webinar replay

Biopharma Dealmaking in 2021: Trends and Transformation

After a turbulent year of remote dealmaking under COVID-19 restrictions, the biopharma sector has kicked off 2021 with renewed vigor. Billion dollar deals abound, merger and acquisition activities are accelerating, and deals are being made earlier and faster than ever.
In this exclusive webinar, Chris Dokomajilar, founder and CEO of DealForma, and Gilles Toulemonde, CEO of Inova, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They'll discuss what deals have been done so far in 2021, identify some of the difficulties that pharma companies are experiencing in attracting biotechs, and explain what to watch in deal making and partnering best practices for the second half of 2021.
Watch this replay to get expert insights from our panelists:
Chris Dokomajilar
Chris Dokomajilar
Founder & CEO
Gilles Toulemonde

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.